PLoS Comput Biol:计算机模拟间充质干细胞疗法 将心脏病治疗风险降至很低

2016-07-27 佚名 生物谷

最近科学家们使用数学计算模型模拟了人类间充质干细胞到达心脏损伤部位的过程,发现只用一个特定亚群的干细胞就能最大限度地减少间充质干细胞疗法带来的相关风险。相关研究结果发表在国际学术期刊Plos Computational Biology上,该研究代表了心肌损伤修复和再生策略的新发展,能够提高干细胞疗法在心脏病患者中的应用安全性。心肌梗死——也即心脏病发作——在美国平均每43秒就会发生。这一情况大大激

最近科学家们使用数学计算模型模拟了人类间充质干细胞到达心脏损伤部位的过程,发现只用一个特定亚群的干细胞就能最大限度地减少间充质干细胞疗法带来的相关风险。相关研究结果发表在国际学术期刊Plos Computational Biology上,该研究代表了心肌损伤修复和再生策略的新发展,能够提高干细胞疗法在心脏病患者中的应用安全性。

心肌梗死——也即心脏病发作——在美国平均每43秒就会发生。这一情况大大激励了科学家们对心肌损伤修复和再生治疗新方法的开发,其中包括人类间充质干细胞治疗。但是在临床试验中间充质干细胞疗法的作用常常比较微弱且短暂,这表明我们对于间充质干细胞如何影响心脏功能的机制仍了解有限。

美国西奈山伊坎医学院的Joshua Mayourian等人使用数学计算模型模拟了这些干细胞与心脏细胞之间的电相互作用,深入了解了其中可能存在的有害影响,同时提出了降低间充质干细胞治疗中一些潜在风险的可能方法。

他们的计算机模拟结果表明一个人类间充质干细胞亚群能够将干细胞对单个心肌细胞和整个组织电活性的干扰降至最小,这群特定的间充质干细胞亚群或可增加心脏病患者接受干细胞治疗的安全性。该研究因此有望引领新的临床研究,并在未来改进对心衰病人的干细胞治疗。

这项研究开发了一个新的数学计算模型未来可用于对间充质干细胞进行计算研究。该研究还为人类间充质干细胞和心脏细胞之间的相互作用提出了新的见解,可以指导未来的实验性研究,进一步理解间充质干细胞用于心脏病治疗的机制.

原始出处

Joshua Mayourian,Ruben M. Savizky,Eric A. Sobie,Kevin D. Costa.Modeling Electrophysiological Coupling and Fusion between Human Mesenchymal Stem Cells and Cardiomyocytes.PLoS Comput Biol.2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1917311, encodeId=90d9191e31131, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Tue Sep 06 03:46:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815247, encodeId=098d181524e0b, content=<a href='/topic/show?id=ae359e231d4' target=_blank style='color:#2F92EE;'>#间充质干细#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97231, encryptionId=ae359e231d4, topicName=间充质干细)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Wed Aug 24 09:46:00 CST 2016, time=2016-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086041, encodeId=dffe2086041f8, content=<a href='/topic/show?id=86499116895' target=_blank style='color:#2F92EE;'>#计算机模拟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91168, encryptionId=86499116895, topicName=计算机模拟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Oct 20 14:46:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767031, encodeId=a8ef1e6703199, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Mar 12 07:46:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716354, encodeId=b07b1e1635406, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Tue Nov 08 09:46:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314452, encodeId=ec8d131445277, content=<a href='/topic/show?id=4c6348e80a9' target=_blank style='color:#2F92EE;'>#干细胞疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48780, encryptionId=4c6348e80a9, topicName=干细胞疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Fri Jul 29 11:46:00 CST 2016, time=2016-07-29, status=1, ipAttribution=)]
    2016-09-06 sunylz
  2. [GetPortalCommentsPageByObjectIdResponse(id=1917311, encodeId=90d9191e31131, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Tue Sep 06 03:46:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815247, encodeId=098d181524e0b, content=<a href='/topic/show?id=ae359e231d4' target=_blank style='color:#2F92EE;'>#间充质干细#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97231, encryptionId=ae359e231d4, topicName=间充质干细)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Wed Aug 24 09:46:00 CST 2016, time=2016-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086041, encodeId=dffe2086041f8, content=<a href='/topic/show?id=86499116895' target=_blank style='color:#2F92EE;'>#计算机模拟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91168, encryptionId=86499116895, topicName=计算机模拟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Oct 20 14:46:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767031, encodeId=a8ef1e6703199, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Mar 12 07:46:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716354, encodeId=b07b1e1635406, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Tue Nov 08 09:46:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314452, encodeId=ec8d131445277, content=<a href='/topic/show?id=4c6348e80a9' target=_blank style='color:#2F92EE;'>#干细胞疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48780, encryptionId=4c6348e80a9, topicName=干细胞疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Fri Jul 29 11:46:00 CST 2016, time=2016-07-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1917311, encodeId=90d9191e31131, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Tue Sep 06 03:46:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815247, encodeId=098d181524e0b, content=<a href='/topic/show?id=ae359e231d4' target=_blank style='color:#2F92EE;'>#间充质干细#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97231, encryptionId=ae359e231d4, topicName=间充质干细)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Wed Aug 24 09:46:00 CST 2016, time=2016-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086041, encodeId=dffe2086041f8, content=<a href='/topic/show?id=86499116895' target=_blank style='color:#2F92EE;'>#计算机模拟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91168, encryptionId=86499116895, topicName=计算机模拟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Oct 20 14:46:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767031, encodeId=a8ef1e6703199, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Mar 12 07:46:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716354, encodeId=b07b1e1635406, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Tue Nov 08 09:46:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314452, encodeId=ec8d131445277, content=<a href='/topic/show?id=4c6348e80a9' target=_blank style='color:#2F92EE;'>#干细胞疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48780, encryptionId=4c6348e80a9, topicName=干细胞疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Fri Jul 29 11:46:00 CST 2016, time=2016-07-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1917311, encodeId=90d9191e31131, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Tue Sep 06 03:46:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815247, encodeId=098d181524e0b, content=<a href='/topic/show?id=ae359e231d4' target=_blank style='color:#2F92EE;'>#间充质干细#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97231, encryptionId=ae359e231d4, topicName=间充质干细)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Wed Aug 24 09:46:00 CST 2016, time=2016-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086041, encodeId=dffe2086041f8, content=<a href='/topic/show?id=86499116895' target=_blank style='color:#2F92EE;'>#计算机模拟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91168, encryptionId=86499116895, topicName=计算机模拟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Oct 20 14:46:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767031, encodeId=a8ef1e6703199, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Mar 12 07:46:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716354, encodeId=b07b1e1635406, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Tue Nov 08 09:46:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314452, encodeId=ec8d131445277, content=<a href='/topic/show?id=4c6348e80a9' target=_blank style='color:#2F92EE;'>#干细胞疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48780, encryptionId=4c6348e80a9, topicName=干细胞疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Fri Jul 29 11:46:00 CST 2016, time=2016-07-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1917311, encodeId=90d9191e31131, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Tue Sep 06 03:46:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815247, encodeId=098d181524e0b, content=<a href='/topic/show?id=ae359e231d4' target=_blank style='color:#2F92EE;'>#间充质干细#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97231, encryptionId=ae359e231d4, topicName=间充质干细)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Wed Aug 24 09:46:00 CST 2016, time=2016-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086041, encodeId=dffe2086041f8, content=<a href='/topic/show?id=86499116895' target=_blank style='color:#2F92EE;'>#计算机模拟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91168, encryptionId=86499116895, topicName=计算机模拟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Oct 20 14:46:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767031, encodeId=a8ef1e6703199, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Mar 12 07:46:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716354, encodeId=b07b1e1635406, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Tue Nov 08 09:46:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314452, encodeId=ec8d131445277, content=<a href='/topic/show?id=4c6348e80a9' target=_blank style='color:#2F92EE;'>#干细胞疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48780, encryptionId=4c6348e80a9, topicName=干细胞疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Fri Jul 29 11:46:00 CST 2016, time=2016-07-29, status=1, ipAttribution=)]
    2016-11-08 bioon14
  6. [GetPortalCommentsPageByObjectIdResponse(id=1917311, encodeId=90d9191e31131, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Tue Sep 06 03:46:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1815247, encodeId=098d181524e0b, content=<a href='/topic/show?id=ae359e231d4' target=_blank style='color:#2F92EE;'>#间充质干细#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97231, encryptionId=ae359e231d4, topicName=间充质干细)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b632500090, createdName=h.y200607_23674418, createdTime=Wed Aug 24 09:46:00 CST 2016, time=2016-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086041, encodeId=dffe2086041f8, content=<a href='/topic/show?id=86499116895' target=_blank style='color:#2F92EE;'>#计算机模拟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91168, encryptionId=86499116895, topicName=计算机模拟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Thu Oct 20 14:46:00 CST 2016, time=2016-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767031, encodeId=a8ef1e6703199, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Mar 12 07:46:00 CST 2017, time=2017-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716354, encodeId=b07b1e1635406, content=<a href='/topic/show?id=d68d911542f' target=_blank style='color:#2F92EE;'>#计算机#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91154, encryptionId=d68d911542f, topicName=计算机)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def632217870, createdName=bioon14, createdTime=Tue Nov 08 09:46:00 CST 2016, time=2016-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1314452, encodeId=ec8d131445277, content=<a href='/topic/show?id=4c6348e80a9' target=_blank style='color:#2F92EE;'>#干细胞疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48780, encryptionId=4c6348e80a9, topicName=干细胞疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5319428, createdName=jjjiang0199, createdTime=Fri Jul 29 11:46:00 CST 2016, time=2016-07-29, status=1, ipAttribution=)]

相关资讯

STEM CELLS:增压干细胞创建新疗法

近日,发表在国际期刊Stem Cells上的一项研究指出,阿德莱德大学的研究人员发现了一种培养干细胞的新方法,该方法可使细胞生长的更快,更强壮。 Kisha Sivanathan博士说这在干细胞上是一个激动人心的突破性研究。“成人间充质干细胞可以从体内许多组织包括骨髓中获得,这种干细胞吸引着世界各地的科学家,因为它们易于培养、源于天然、治疗效果好。这些干细胞用于治疗许多种炎性疾病,研究人员一直在

Nat Commun:干细胞疗法治疗糖尿病日渐成熟 科学家已经实现利用病人组织获得β细胞

(上图表明病人组织来源β细胞与正常人组织来源β细胞的分子标记无差异)   最近,来自华盛顿大学医学院和哈佛大学的研究人员利用1型糖尿病病人组织形成的诱导多能干细胞分化得到具有胰岛素分泌功能的β细胞,为治疗糖尿病找到一个新的潜在方法。1型糖尿病病人自身无法合成胰岛素,因此需要常规注射胰岛素帮助控制血糖。这项最新发现表明糖尿病个体化治疗已见曙光。   相关研究结果发表在

太深?Teva放弃一个III期心衰干细胞疗法的开发权利

Teva近日宣布将MPC-150-IM的开发权利全部归还给澳大利亚Mesoblast公司。 Teve决定放弃开发MPC-150-IM,但是Mesoblast表示将继续推进这个项目,并且会寻找新的合作伙伴来推进MPC-150-IM的上市以及全球销售工作。Mesoblast表示MPC-150-IM的后续研发费用大约要1亿美元,公司有足够的现金来完成相关研发工作。 Mesoblast称,独立的数

Stroke:干细胞疗法可有效治疗中风

  (图片摘自www.sciencealert.com)   患有中风的患者在经过向大脑中注射干细胞治疗,能够明显地提高其讲话能力、身体强度以及行动力。其中一些患者甚至能够重新行走。   这一临床试验的成功意味着我们低估了大脑自愈的能力,也许有一天这种疗法能够使大脑重新恢复功能。   "一位71岁的老年女性在治疗开始前仅仅能够活动左手大拇指

Neurology:临床试验证明干细胞疗法治疗“渐冻症”的安全性 解救“渐冻人”有望落实行动

日前一项对肌萎缩侧索硬化症(ALS)病人进行的2期临床试验表明将人类干细胞移植到病人的脊髓中已经具备安全性,有望扩大临床试验样本量进一步验证干细胞疗法治疗ALS的效果。该研究发表在国际学术期刊Neurology上。 ALS是脑和脊髓运动神经元退化导致的一种神经紊乱疾病,该病患者会逐渐失去肌肉控制能力,包括呼吸和吞咽,最终导致死亡。目前仍然没有有效方法可以阻止这种疾病。 参与该研究的

Nature:千呼万唤始出来 中国颁布干细胞管理规范

干细胞疗法是本世纪最有前景的疗法之一。研究人员通过利用干细胞能够分化为多种细胞类型的能力来设计疗法,可以用于治疗癌症、糖尿病以及神经退行性疾病等多个领域的疾病。在这一领域,中国也不落人后。许多科学家都在该领域做出了出色的工作。据统计,2014年中国科学家发表的关于干细胞方面的论文数已经超过了日本,仅次于美国。(相关阅读:中国在干细胞领域发表论文数超过日本)然而,在干细胞疗法方面,中国和世界上许多其